Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
about
Critical Limb Ischemia: Current Trends and Future DirectionsBuerger's disease: providing integrated careMesenchymal stromal cells for the treatment of critical limb ischemia: context and perspectiveBilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial.Biological strategies for improved osseointegration and osteoinduction of porous metal orthopedic implantsCell Therapy for Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials.Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.Therapeutic strategies for cell-based neovascularization in critical limb ischemiaWhat can I do with a patient with diabetes and critically impaired limb perfusion who cannot be revascularized?Cell-based therapy approaches: the hope for incurable diseases.Peripheral arterial disease and revascularization of the diabetic foot.The diabetic foot in 2015: an overview.Current therapies and investigational drugs for peripheral arterial disease.Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes.Characterization of the Cellular Output of a Point-of-Care Device and the Implications for Addressing Critical Limb Ischemia.Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.Conservative Treatment in Selected Patients with Severe Critical Limb Ischemia.Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.Role of serum levels of angiogenic cytokines in assessment of angiogenesis after stem cell therapy of diabetic patients with critical limb ischemia.Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.Adjuvant Biological Therapies in Chronic Leg Ulcers.An endovascular model of ischemic myopathy from peripheral arterial disease.Review of the Latest Percutaneous Devices in Critical Limb Ischemia.Critical limb ischemia: current challenges and future prospects.
P2860
Q26767021-1E3F795F-35C8-4AF0-90D1-EA07CA8CAAFDQ28072543-26975FBB-8D4F-4D0A-916E-ED254D34E676Q33746356-639E620E-CA28-40A6-827C-2B751AC9792BQ34620003-7DB9A8DD-04EF-42F0-93ED-AAFE281004DAQ35323590-2338C1EB-EF84-442C-83FA-10FC47AEFE77Q35701604-2CC7BAF7-B832-4197-A928-49C55C2E651DQ36105161-EC79ADD9-1667-46E4-997C-FC5036CF5846Q36501065-3F5C0229-257C-48BF-A596-9A4C4A88F62DQ37663453-5695EB7A-56D0-470E-A72A-A4273DD07749Q38261175-5C0BAB6A-57D1-46C7-B779-0B85B601B148Q38265206-86F053F9-969B-4270-AD2D-79E7873089E2Q38282150-748434DB-0029-4C25-8C34-11C50C6B6DB5Q38602992-FB588F8A-CF12-4BB5-900F-62206028D806Q38657444-B4844099-699C-4C79-9F76-7CFAC4F5DF3BQ38843000-CFCF6774-2BE4-46D2-9387-7D67741964DCQ40244927-77771C5D-21BC-4CDD-B33E-8A04C77A45D6Q40611142-53ADA0F1-E7B8-4864-BA05-13DA5D561CA9Q41039218-1DED611D-D059-4879-B89A-D6C3DE6B9A7EQ42181707-17A4709F-A856-45F2-B616-13F567502884Q45731764-2869EB95-88C0-4429-B38F-0D0DC0BF9F24Q48062750-DFB795AF-D7EC-4C03-8EA4-60D5689E6053Q48144378-3E32593E-5BE7-40F1-A03A-FB17B3F52557Q49283538-23A43FAC-3A35-4B33-89EF-F8DF7B0A9CA7Q51148798-BDE8113E-4198-4A00-8DAA-52F415A05D93Q52584675-FE2067E7-C7D3-463C-AD44-F9B883A84D96Q54976893-CD99B220-4D2C-436F-A693-FE69C929CAD8
P2860
Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Autologous bone marrow-derived ...... ed controlled clinical trials.
@en
Autologous bone marrow-derived ...... ed controlled clinical trials.
@nl
type
label
Autologous bone marrow-derived ...... ed controlled clinical trials.
@en
Autologous bone marrow-derived ...... ed controlled clinical trials.
@nl
prefLabel
Autologous bone marrow-derived ...... ed controlled clinical trials.
@en
Autologous bone marrow-derived ...... ed controlled clinical trials.
@nl
P2093
P1433
P1476
Autologous bone marrow-derived ...... ed controlled clinical trials.
@en
P2093
Charmaine E J Peters
Frans L Moll
Ralf W Sprengers
Yolanda van der Graaf
P304
P356
10.1097/SLA.0B013E3182854CF1
P407
P577
2013-12-01T00:00:00Z